Chronic pain, prescribed opioids and overdose risk: a qualitative exploration of the views of affected individuals and family members

Parkes, Tessa; Foster, Rebecca; McAuley, Andrew; Steven, Deborah; Matheson, Catriona; Baldacchino, Alex

doi:10.1080/09687637.2021.2022100

Cited by 2 publications

(8 citation statements)

References 67 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The findings reported in the current paper (and those in Parkes et al [21] and Schofield et al [8]) informed the final intervention with the idea to conduct a feasibility trial in the future. This paper outlines key stakeholder perceptions of a bespoke overdose prevention intervention tailored to CNCP patients prescribed high‐strength opioids.…”

Section: Discussionmentioning

confidence: 60%

“…Different elements of the current study have been reported in Schofield et al [8] and Parkes et al [21]. These two papers contextualise findings from the current paper within a broader context of perspectives of CNCP pain and overdose risk, and prevalence of patients at overdose risk within the health board where the research was conducted.…”

Section: Introductionmentioning

confidence: 81%

“…A researcher (Tyler Browne) uploaded transcripts to NVivo (Version 12) and coded and analysed them with support from RF using the Framework approach [23]. For full details for the analysis process, please see Parkes et al [21].…”

Section: Methodsmentioning

confidence: 99%

“…These two papers contextualise findings from the current paper within a broader context of perspectives of CNCP pain and overdose risk, and prevalence of patients at overdose risk within the health board where the research was conducted. For insight into perspectives of chronic pain, prescribed opioids and overdose risk, Parkes et al [21] documented the views of those prescribed opioids for CNCP and family members, given these voices are often under‐represented within the literature. Findings represented in the Parkes et al [21] paper helped to develop the intervention which is reported in the current paper.…”

Section: Introductionmentioning

confidence: 99%

“…For insight into perspectives of chronic pain, prescribed opioids and overdose risk, Parkes et al [21] documented the views of those prescribed opioids for CNCP and family members, given these voices are often under‐represented within the literature. Findings represented in the Parkes et al [21] paper helped to develop the intervention which is reported in the current paper. Important findings which shaped the current intervention included: living with pain and experiencing stigma; pragmatic issues such as potential side effects of prescribed opioids or taking more than prescribed; the role of prescribers in overdose risk and prevention; and attitudes towards naloxone to address overdose risk.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high‐strength opioids for chronic non‐cancer pain: An explorative intervention development study

Mercer

Parkes

Foster

et al. 2022

Drug and Alcohol Review

Self Cite

View full text Add to dashboard Cite

Introduction: Despite opioid prescribing for chronic non-cancer pain (CNCP) having limited therapeutic benefits, recent evidence indicates significant increases in the prescribing of high-strength opioids for individuals with CNCP. Patients prescribed opioids for CNCP have overdose risk factors but generally have low opioid overdose awareness and low perceptions of risk related to prescribed opioids. Currently, there are few bespoke overdose prevention resources for this group.Methods: This qualitative study investigated views on a naloxone intervention for people prescribed high-strength opioids for CNCP delivered via community pharmacies. The intervention included overdose risk awareness and naloxone training and provision. Interviews were conducted with eight patients, four family members and two community pharmacists. Participants were convenience sampled and recruited through networks within the Scottish pain community. The Framework approach was used to analyse findings.Results: All participants had positive attitudes towards the intervention, but patients and family members considered risk of overdose to be very low. Three themes were identified: potential advantages of the intervention; potential barriers to the intervention; and additional suggestions and feedback about the intervention. Advantages included the intervention providing essential overdose information for CNCP patients. Barriers included resource and time pressures within community pharmacies.Discussion and Conclusion: While patients had low overdose knowledge and did not see themselves as being at risk of opioid overdose, they were receptive to naloxone use and positive about the proposed intervention. A feasibility trial is

show abstract

Section: Discussionmentioning

confidence: 60%

Section: Introductionmentioning

confidence: 81%

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high‐strength opioids for chronic non‐cancer pain: An explorative intervention development study

Mercer

Parkes

Foster

et al. 2022

Drug and Alcohol Review

Self Cite

View full text Add to dashboard Cite

show abstract

Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain

et al. 2023

Self Cite

View full text Add to dashboard Cite

There have been increases in prescriptions of high strength opioids for chronic non-cancer pain (CNCP), but CNCP patients perceive themselves as being at low risk of opioid overdose and generally have limited overdose awareness. This study examined how an overdose prevention intervention (opioid safety education, naloxone training, and take-home naloxone (THN)) delivered by community pharmacists for patients prescribed high-strength opioids for CNCP would work in practice in Scotland. Twelve patients received the intervention. CNCP patients and Community Pharmacists were interviewed about their experiences of the intervention and perceptions of its acceptability and feasibility. CNCP patients did not initially perceive themselves as being at risk of overdose but, through the intervention, developed insight into opioid-related risk and the value of naloxone. Pharmacists also identified patients’ low risk perceptions and low overdose awareness. While pharmacists had positive attitudes towards the intervention, they outlined challenges in delivering it under time and resource pressures and during the COVID-19 pandemic. Overdose prevention interventions are required in the CNCP population as this group has elevated risk factors for overdose but are commonly overlooked. Customised overdose prevention interventions for CNCP patients attend to gaps in overdose awareness and risk perceptions in this population.

show abstract

Chronic pain, prescribed opioids and overdose risk: a qualitative exploration of the views of affected individuals and family members

Cited by 2 publications

References 67 publications

Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high‐strength opioids for chronic non‐cancer pain: An explorative intervention development study

Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high‐strength opioids for chronic non‐cancer pain: An explorative intervention development study

Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain

Contact Info

Product

Resources

About